Increased hepatic density and phospholipidosis due to amiodarone

IS Goldman, ML Winkler, SE Raper… - American journal of …, 1985 - Am Roentgen Ray Soc
Amiodarone is an amphiphilic iodinated compound that is used as a treatment for refractory
ventricular arrhythmias. During evaluation for possible pulmonary toxicity, a patient receiving …

Abnormal abdominal computerized tomography with amiodarone therapy and clinical significance

M Shenasa, U Vaisman, M Wojciechowski… - American Heart …, 1984 - Elsevier
Although the antiarrhythmic agent, amiodarone, is known to cause elevation of liver function
tests, the effect of this drug on abdominal computerized tomography (CT) scans in patients …

Long-term amiodarone therapy: a cause of increased hepatic attenuation on CT

D Patrick, FE White, PC Adams - The British journal of radiology, 1984 - academic.oup.com
Approximately 40% of the anti-arrhythmic drug, amiodarone, consists of iodine. During long-
term therapy both the drug and its major metabolite, desethylamiodarone, are deposited in …

Increased Density of the Liver and Amiodarone‐Associated Phospholipidosis

S Kojima, S Kojima, H Ueno, M Takeya… - … research and practice, 2009 - Wiley Online Library
This is a case report in which a 60‐year‐old man who suffered from ventricular tachycardia
with dilated cardiomyopathy was prescribed amiodarone. After taking amiodarone, liver …

Value of hepatic computerized tomographic scanning during amiodarone therapy

J Markos, ME Veronese, MR Nicholson… - The American journal of …, 1985 - Elsevier
Amiodarone therapy is difficult to monitor because of the poor correlation between plasma
amiodarone levels and clinical efficacy or toxicity. Monitoring tissue levels may give a better …

Lung disease caused by amiodarone, a new antiarrythmic agent.

WB Gefter, DM Epstein, GG Pietra, WT Miller - Radiology, 1983 - pubs.rsna.org
Amiodarone hydrochloride, used for prophylaxis of recurrent ventricular tachyarrhythmias
that are resistant to other agents, may cause toxic pulmonary reactions associated with …

Amiodarone hepatotoxicity: a clinicopathologic study of five patients

B RIGAS, LE ROSENFELD, KW BARWICK… - Annals of Internal …, 1986 - acpjournals.org
Five patients had amiodarone hepatotoxicity detected on routine biochemical monitoring.
Symptoms attributable to hepatotoxicity were minimal or absent; reversible hepatomegaly …

Hepatic cirrhosis caused by low-dose oral amiodarone therapy

SR Puli, MA Fraley, V Puli, AB Kuperman… - The American journal of …, 2005 - Elsevier
A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once
per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular …

Amiodarone pulmonary toxicity: CT findings in symptomatic patients.

JE Kuhlman, C Teigen, H Ren, RH Hruban… - Radiology, 1990 - pubs.rsna.org
The computed tomographic (CT) chest scans of 11 patients who developed respiratory or
constitutional symptoms while receiving amiodarone therapy were reviewed. CT findings …

Amiodarone hepatotoxicity with absent phospholipidosis and steatosis: a case report and review of amiodarone toxicity in various organs

A Cimic, J Sirintrapun - Case reports in pathology, 2013 - Wiley Online Library
We present the first description of amiodarone toxicity in the liver without phospholipidosis or
steatosis. In doing so, we will review the various effects of amiodarone toxicity in various …